Keryx Biopharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 1.0 | 0.5 | 0.6 |
| Cost of Goods Sold | 0.2 | 0.5 | 0.8 |
| Gross Profit | 0.9 | 0.0 | (0.3) |
| Gross Profit Margin | 84.8% | 0.0% | 0.0% |
| SG&A Expense | 95.3 | 79.9 | 28.8 |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 |
| Operating Income | (94.6) | (80.2) | (29.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 4.6 | 6.4 | 2.3 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (90.0) | (73.8) | (26.9) |
| Income Taxes | 0.0 | -- | -- |
| Net Income After Taxes | (90.1) | (73.8) | (26.9) |
| Continuing Operations | (90.1) | (73.8) | (26.9) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (90.1) | (73.8) | (26.9) |
| Total Net Income | (90.1) | (73.8) | (26.9) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (2.07) | (1.76) | (0.78) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
